David Norman

Anal cancer in Sweden 2015–2019. Implementation of guidelines, structural changes, national registry and early results

B. Zackrisson, E. Angenete, M. Lydrup, 2022, Acta oncologica.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.

L. Beckman, B. Zackrisson, P. Fransson, 2021, The Lancet. Oncology.

Ultrahypofractionation for prostate cancer : Outcome from the Scandinavian phase 3 HYPO-RT-PC trial

L. Beckman, P. Fransson, B. Johansson, 2018 .

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

L. Beckman, B. Zackrisson, P. Fransson, 2019, The Lancet.